谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Validation of Prototype Biomarkers to Identify Risk Factors of Inflammatory Adverse Events (iaes) Following Idecabtagene Vicleucel (Ide-Cel) Infusion in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) in KarMMa-3.

Sanhita Sengupta, Clara Amorosi,Mandeep Takhar,Yi Lin,Salomon Manier,Rachid C. Baz, Krishna Rangadhamarao Juluri, Allison Kaeding,Afshin Mashadi-Hossein,Julia Piasecki,Timothy Brandon Campbell,Shari Kaiser,Julie Rytlewski,Md Shamsuzzaman,Nathan Martin

Journal of Clinical Oncology（2024）

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要